CannBioRx Life Sciences Corp. (ATNFW)
USD 0.01
(5.63%)
USD 0.01
(5.63%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 13.47 Million USD | -43.9% |
| 2022 | 39.64 Million USD | 96.62% |
| 2021 | 20.16 Million USD | 105.36% |
| 2020 | 9.81 Million USD | -61.08% |
| 2019 | 25.22 Million USD | 73.85% |
| 2018 | 14.5 Million USD | 4118.77% |
| 2017 | 343.88 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.82 Million USD | -10.74% |
| 2024 Q1 | 2.06 Million USD | 69.38% |
| 2023 Q4 | 1.22 Million USD | -90.31% |
| 2023 FY | 22.23 Million USD | -43.9% |
| 2023 Q3 | 12.59 Million USD | 243.44% |
| 2023 Q2 | 3.66 Million USD | -22.78% |
| 2023 Q1 | 4.75 Million USD | -79.05% |
| 2022 FY | 39.64 Million USD | 96.62% |
| 2022 Q4 | 22.67 Million USD | 5.59% |
| 2022 Q3 | 21.47 Million USD | 628.52% |
| 2022 Q2 | 2.94 Million USD | 88.19% |
| 2022 Q1 | 1.56 Million USD | 50.21% |
| 2021 Q2 | 23.43 Million USD | 45.79% |
| 2021 FY | 20.16 Million USD | 105.36% |
| 2021 Q1 | 16.07 Million USD | 119.27% |
| 2021 Q4 | 1.04 Million USD | -94.3% |
| 2021 Q3 | 18.31 Million USD | -21.88% |
| 2020 Q4 | 7.33 Million USD | 906.51% |
| 2020 FY | 9.81 Million USD | -61.08% |
| 2020 Q1 | 2.21 Million USD | -90.94% |
| 2020 Q2 | 456.76 Thousand USD | -79.37% |
| 2020 Q3 | 728.47 Thousand USD | 59.49% |
| 2019 Q1 | 280.64 Thousand USD | -93.5% |
| 2019 Q4 | 24.43 Million USD | 10726.43% |
| 2019 Q3 | 225.69 Thousand USD | -23.85% |
| 2019 FY | 25.22 Million USD | 73.85% |
| 2019 Q2 | 296.37 Thousand USD | 5.61% |
| 2018 Q1 | 137.87 Thousand USD | 0.0% |
| 2018 Q3 | 1.53 Million USD | 940.04% |
| 2018 Q2 | 147.97 Thousand USD | 7.33% |
| 2018 FY | 14.5 Million USD | 4118.77% |
| 2018 Q4 | 4.31 Million USD | 180.59% |
| 2017 Q3 | 140.84 Thousand USD | 179.26% |
| 2017 Q2 | 50.43 Thousand USD | 0.0% |
| 2017 FY | 343.88 Thousand USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| BIMI International Medical Inc. | 17.28 Million USD | 22.043% |
| China Jo-Jo Drugstores, Inc. | 34.64 Million USD | 61.096% |
| Harrow Health, Inc. 8.625% Senior Notes due 2026 | 89.97 Million USD | 85.021% |
| Harrow Health, Inc. 11.875% Senior Notes due 2027 | 90.12 Million USD | 85.045% |
| Leafly Holdings, Inc. | 44.5 Million USD | 69.715% |
| Leafly Holdings, Inc. | 44.5 Million USD | 69.715% |
| LifeMD, Inc. | 148.13 Million USD | 90.902% |
| LifeMD, Inc. | 148.13 Million USD | 90.902% |
| TRxADE HEALTH, Inc. | 9.86 Million USD | -36.666% |
| PetMed Express, Inc. | 86.81 Million USD | 84.475% |
| Walgreens Boots Alliance, Inc. | 40.6 Billion USD | 99.967% |